Full name
CENTRUM BADAWCZE FORTISMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
62.09.Z - Other information technology and computer service activities
63.99.Z - Other information service activities not elsewhere classified
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -27,7 | -23,7 | -23,7 | -0,2 |
Gross profit (loss) | -27,7 | -23,7 | -23,7 | -0,2 |
EBITDA | ||||
Short time liabilities | 61,5 | 84 | 106,2 | 26,4 |
Other operating costs | 0 | 0 | -100 | |
Equity capital | -46,4 | -70,1 | -93,8 | -33,8 |
Operating profit (EBIT) | -27,7 | 10,9 | ||
Assets | 15 | 13,9 | 12,4 | -11 |
Net profit (loss) | -27,7 | -23,7 | -23,7 | -0,2 |
Cash | 3,1 | 1,9 | 0,4 | -80,4 |
Net income from sale | ||||
Liabilities and provisions for liabilities | 61,5 | 84 | 106,2 | 26,4 |
Working assets | 8 | 6,8 | 5,3 | -22,4 |
Other income costs | 0 | -100 | ||
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | 59,7 | 33,8 | 25,3 | -8,5 |
Equity capital to total assets | -308,6 | -505,2 | -759,6 | -254,4 |
Gross profit margin | ||||
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | ||||
Current financial liquidity indicator | 0.12969936430454254 | 0.08100814372301102 | 0.049717098474502563 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane